Product Comparison


 
Sanofi Pasteur 562-10
Glaxo Smith Kline 58160081252
Glaxo Smith Kline 58160081211
McKesson # 974482 764549 666268
Description Quadracel™ DTaP and Polio Vaccine 4 to 6 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine Injection Single Dose Vial 0.5 mL Kinrix® DTaP and Polio Vaccine 4 to 6 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus Vaccine, Preservative Free Injection Prefilled Syringe 0.5 mL Kinrix® DTaP and Polio Vaccine 4 to 6 Years of Age Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus Vaccine, Preservative Free Injection Single Dose Vial 0.5 mL
Manufacturer # 562-105816008125258160081211
Brand Quadracel™Kinrix®Kinrix®
Manufacturer Sanofi PasteurGlaxo Smith KlineGlaxo Smith Kline
Invoice QUADRACEL, SDV 0.5ML (10/BX)KINRIX VACCINE, SYR 25-25-10MG/0.5ML 0.5ML (10/PK)KINRIX VACCINE, SDV 0.5ML (10/PK)
    Log In to Order   Log In to Order   Log In to Order

Comparison

Container Type Single Dose VialPrefilled SyringeSingle Dose Vial
Country of Origin CanadaUnknownUnknown
Generic Drug Code 9983199830
Generic Drug Name Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus VaccineDiphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus Vaccine, Preservative FreeDiphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus Vaccine, Preservative Free
NDC Number 49281-0562-1058160-0812-5258160-0812-11
Strength 15 Lf - 5 Lf - 20 mcg25 Lf - 10 Lf - 25 mcg25 Lf - 10 Lf - 25 mcg
UNSPSC Code 512021005120160051201600
Application DTaP and Polio VaccineDTaP and Polio VaccineDTaP and Polio Vaccine
Dosage Form InjectionInjectionInjection
Product Dating McKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 daysMcKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires Refrigeration
Type IntramuscularIntramuscularIntramuscular
User 4 to 6 Years of Age4 to 6 Years of Age4 to 6 Years of Age
Volume 0.5 mL0.5 mL0.5 mL
Features and Benefits
  • Quadracel is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis and poliomyelitis
  • A single dose of Quadracel is approved for use in children 4 through 6 years of age as a fifth dose in the diphtheria, tetanus, pertussis vaccination (DTaP) series, and as a fourth or fifth dose in the inactivated poliovirus vaccination (IPV) series, in children who have received 4 doses of Pentacel and/or DAPTACEL vaccine
  • Each 0.5 mL dose is formulated to contain 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, acellular pertussis antigens [20 mcg detoxified pertussis toxin (PT), 20 mcg filamentous hemagglutinin (FHA), 3 mcg pertactin (PRN), 5 mcg fimbriae types 2 and 3 (FIM)], and inactivated polioviruses [40 D-antigen units (DU) Type 1 (Mahoney), 8 DU Type 2 (MEF-1), 32 DU Type 3 (Saukett)]
  • KINRIX may be used for the fifth dose in the DTaP immunization series and the fourth dose in the IPV immunization series in children 4 through 6 years of age (prior to the seventh birthday) whose previous DTaP vaccine doses have been with INFANRIX and/or PEDIARIX for the first three doses and INFANRIX for the fourth dose
  • Prefilled TIP-LOK syringe without needle
  • Store refrigerated between 2 and 8 degrees C (36 and 46 degrees F)
  • KINRIX may be used for the fifth dose in the DTaP immunization series and the fourth dose in the IPV immunization series in children 4 through 6 years of age (prior to the seventh birthday) whose previous DTaP vaccine doses have been with INFANRIX and/or PEDIARIX for the first three doses and INFANRIX for the fourth dose
  • Store refrigerated between 2 and 8 degrees C (36 and 46 degrees F)